Skip to Content
Merck

Heterocyclic bibenzimidazole derivatives as topoisomerase I inhibitors.

Bioorganic & medicinal chemistry letters (2000-04-27)
S Jin, J S Kim, S P Sim, A Liu, D S Pilch, L F Liu, E J LaVoie
ABSTRACT

A series of 2'-heterocyclic derivatives of 5-phenyl-2,5'-1H-bibenzimidazoles were evaluated for topoisomerase I poisoning activity and cytotoxicity. Topo I poisoning activity was associated with 2'-derivatives that possessed a hydrogen atom capable of hydrogen bond formation, suggesting that the interatomic distances between such hydrogen atoms and the heteroatoms on the adjacent benzimidazole influence activity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Indole-5-carboxaldehyde, 98%